MedTrace Logo

To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions

NCT00913718 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2017-03-28

No results posted yet for this study

Summary

To demonstrate the relative bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride capsules (Pulvules) in healthy adult males under fasting conditions.

Conditions

Interventions

DRUG

Fluoxetine Hydrochloride 20 mg Capsules (Geneva Pharmaceutical, Inc.)

DRUG

Prozac Fluoxetine Hydrochloride 20 mg Capsules (Dista)

Sponsors & Collaborators

Principal Investigators

  • Roderick Malone, M.D. · Clinical Research Center (Cincinnati)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-06-30
Primary Completion
1996-07-31
Completion
1996-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913718 on ClinicalTrials.gov